A comparison of adjuvant psychological therapy and supportive counselling in patients with cancer

Psycho-oncology
S MooreyM Law

Abstract

This study compared the effectiveness of two psychological treatments in a group of 57 patients with various types of cancer attending the Royal Marsden Hospital. Patients referred for psychiatric assessment who met criteria for an abnormal adjustment reaction were randomly allocated to either 8 weeks of Adjuvant Psychological Therapy (APT), a problem-focused, cognitive behavioural treatment programme, or 8 weeks of a comparison treatment of supportive counselling. At 8 weeks from the baseline assessment, APT had produced a significantly greater change than the counselling intervention on fighting spirit, helplessness, coping with cancer, anxiety, and self-defined problems. At 4 months from baseline, APT had produced a significantly greater change than counselling on fighting spirit, coping with cancer, anxiety and self defined problems. It is concluded that APT produces greater change in anxiety, adjustment to cancer and use of coping strategies than a non-directive, supportive intervention over an 8 week period of treatment. This difference persists at follow up 4 months after baseline assessment.

References

Mar 14, 1992·BMJ : British Medical Journal·S GreerJ M Bliss
Jan 1, 1986·Psychotherapy and Psychosomatics·I Marks
Jan 1, 1987·Behaviour Research and Therapy·C BlowersA Mathews
Jun 1, 1970·Journal of Consulting and Clinical Psychology·G J Allen
Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
Nov 29, 1980·British Medical Journal·P MaguireR Sellwood
Jun 1, 1961·Archives of General Psychiatry·A T BECKJ ERBAUGH

❮ Previous
Next ❯

Citations

Sep 29, 2009·Journal of Behavioral Medicine·Stefan SchneiderValerie Targhetta
Oct 16, 2001·General Hospital Psychiatry·L BaiderU Koch
Jan 8, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C PitceathlyF Creed
Jul 7, 2012·Journal of the National Cancer Institute·Stacey L HartAnnette L Stanton
Jul 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Katherine N DuHamelWilliam H Redd
Jul 2, 2002·Journal of Consulting and Clinical Psychology·Barbara L Andersen
May 27, 2008·Behavior Therapy·Derek R HopkoCarl W Lejuez
Jan 16, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hermann FallerRoland Küffner
Nov 23, 2012·Palliative & Supportive Care·Tomer T LevinDavid W Kissane
Apr 21, 2018·Journal of Palliative Medicine·Jessica J FultonKatherine Ramos
Jul 6, 2011·The American Journal of Hospice & Palliative Care·Emily Kathryn Stagg, Mark Lazenby
Sep 14, 2002·Psycho-oncology·A MathewsP Britton
Jun 30, 2018·Journal of Traumatic Stress·Meaghan L O'DonnellTracey Varker
Jun 1, 2006·Current Psychiatry Reports·Kathryn M KashElisabeth J S Kunkel
Apr 15, 2003·Current Neurology and Neuroscience Reports·Robert J Ferguson, Tim A Ahles
Jan 16, 2014·Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India·M K Taneja
Jan 6, 2005·Cancer Nursing·Cherith J SempleW George Kernohan
Jun 21, 2017·International Journal of Psychiatry in Medicine·Ng Chong GuanNor Zuraida Zainal
Jun 12, 2020·Internet Interventions : the Application of Information Technology in Mental and Behavioural Health·A C LetermeD Servant
Apr 29, 2021·Clinical Psychology & Psychotherapy·Manuela Polidoro LimaTatiana Quarti Irigaray

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.